Down regulation of hepatic glucocorticoid receptors after endotoxin treatment
- PMID: 6840856
- PMCID: PMC264898
- DOI: 10.1128/iai.40.2.613-621.1983
Down regulation of hepatic glucocorticoid receptors after endotoxin treatment
Abstract
The mechanism by which endotoxin administration results in hypoglycemia was evaluated by characterizing [3H]dexamethasone binding and phosphoenolpyruvate carboxykinase activity in hepatic cytosol preparations from treated and control mice. Starved mice were given Escherichia coli O111:B4 endotoxin or saline intraperitoneally on day 3 after bilateral adrenalectomy. [3H]dexamethasone binding was measured by the charcoal method after the incubation of cytosol preparations with [3H]dexamethasone in the presence or absence of unlabeled dexamethasone. Changes in [3H]dexamethasone binding were found to be time and dose dependent in treated mice. When mice given different doses of endotoxin reached the same stage of morbidity, as indicated by the average time of death, significantly lower glucocorticoid binding was measured. Scatchard analysis of binding isotherms defined a single class of binding sites. Association and dissociation rate constants and the equilibrium dissociation constant (Kd) were not altered, but the maximum number of binding sites was depressed by endotoxin. The rank order of potency of competitors for [3H]dexamethasone binding, dexamethasone greater than hydrocortisone = corticosterone greater than deoxycorticosterone greater than progesterone greater than testosterone = estradiol, was consistent with a glucocorticoid receptor, although the competition was not altered by endotoxin. Endotoxin treatment prevented the glucocorticoid-induced increase in hepatic phosphoenolpyruvate carboxykinase activity. We conclude that the hypoglycemia of endotoxin poisoning is effected, in part, by the inhibition of the glucocorticoid-mediated induction of phosphoenolpyruvate carboxykinase via the down regulation of hepatic glucocorticoid receptors.
Similar articles
-
Endotoxin treatment inhibits glucocorticoid induction of hepatic enzymes at a late induction step.Am J Physiol. 1986 Feb;250(2 Pt 1):E218-25. doi: 10.1152/ajpendo.1986.250.2.E218. Am J Physiol. 1986. PMID: 3513609
-
General effect of endotoxin on glucocorticoid receptors in mammalian tissues.Circ Shock. 1986;18(4):301-9. Circ Shock. 1986. PMID: 3084123
-
Influence of endotoxin treatment on dexamethasone induction of hepatic phosphoenolpyruvate carboxykinase.Infect Immun. 1983 Jan;39(1):213-9. doi: 10.1128/iai.39.1.213-219.1983. Infect Immun. 1983. PMID: 6822414 Free PMC article.
-
Effects of aging and endotoxin on hepatic glucocorticoid action and glucose metabolism in mice.Mech Ageing Dev. 1985 Apr;30(1):73-8. doi: 10.1016/0047-6374(85)90060-0. Mech Ageing Dev. 1985. PMID: 3999815
-
Endotoxin-induced inhibition of steroid binding by mouse liver cytosol.Circ Shock. 1982;9(4):357-67. Circ Shock. 1982. PMID: 6749321
Cited by
-
Pituitary-Adrenal Responses and Glucocorticoid Receptor Expression in Critically Ill Patients with COVID-19.Int J Mol Sci. 2021 Oct 25;22(21):11473. doi: 10.3390/ijms222111473. Int J Mol Sci. 2021. PMID: 34768903 Free PMC article. Review.
-
General Adaptation in Critical Illness: Glucocorticoid Receptor-alpha Master Regulator of Homeostatic Corrections.Front Endocrinol (Lausanne). 2020 Apr 22;11:161. doi: 10.3389/fendo.2020.00161. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 32390938 Free PMC article. Review.
-
Glucocorticoid receptor mRNA levels are selectively decreased in neutrophils of children with sepsis.Intensive Care Med. 2009 Jul;35(7):1247-54. doi: 10.1007/s00134-009-1468-6. Epub 2009 Apr 17. Intensive Care Med. 2009. PMID: 19373457 Free PMC article.
-
Suppression of CRTC2-mediated hepatic gluconeogenesis by TRAF6 contributes to hypoglycemia in septic shock.Cell Discov. 2016 Dec 13;2:16046. doi: 10.1038/celldisc.2016.46. eCollection 2016. Cell Discov. 2016. PMID: 27990298 Free PMC article.
-
Glucocorticoids as cytokine inhibitors: role in neuroendocrine control and therapy of inflammatory diseases.Mediators Inflamm. 1993;2(4):263-70. doi: 10.1155/S0962935193000365. Mediators Inflamm. 1993. PMID: 18475532 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources